Login to Your Account



Turning Point: Chinese Vaccine Gets WHO Stamp of Approval

By Shannon Ellis
Staff Writer

Wednesday, October 23, 2013

SHANGHAI – Marking a turning point for Chinese biotechnology, a company from Sichuan province – Chengdu Institute of Biological Products Co. Ltd. (CIBP) – has earned coveted pre-qualification status from the World Health Organization (WHO) for its Japanese encephalitis (JE) vaccine. It’s the first time a Chinese vaccine maker has earned a WHO seal of approval, which opens up markets worldwide.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription